LH|Analyst Targets
LH|Company Info
LH|Insider Trading
LH|Fundamentals
LH|Earnings Snapshot
EPS
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $4.65 | - | - |
| Q2'26 | $4.92 | $4.99 | +1.4% |
| Q1'26 | $4.22 | $4.25 | +0.8% |
| Q4'25 | $3.94 | $4.07 | +3.2% |
| Q3'25 | $4.14 | $4.18 | +1.0% |
| Q2'25 | $4.18 | $4.35 | +4.1% |
Revenue
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $3.9B | - | - |
| Q2'26 | $3.8B | $3.7B | -2.4% |
| Q1'26 | $3.6B | $3.5B | -2.0% |
| Q4'25 | $3.6B | $3.5B | -1.2% |
| Q3'25 | - | $3.6B | - |
| Q2'25 | - | $3.5B | - |
LH|Monthly Returns
Market Data
LH Stock Snapshot
- Market cap
- 25.44B
- P/E ratio
- 25.4
- Day range
- $314.10 – $319.75
- News sentiment
- 47/100 · Neutral
- Analyst target
- $345.12 (+8.7%)
- Consensus
- Buy · 29 analysts
LH sits in the upper part of its 52-week range with the technical picture unresolved. In Healthcare, names this size usually take direction from sector flows before company-level news.
Reverse DCF
What growth is priced into LH?
At today's price, Labcorp Holdings Inc. needs to grow free cash flow about 7.9% a year for the next 10 years to justify its valuation at a 7.55% cost of capital. Over its actual history it has compounded free cash flow at 5.4% a year, so the market is asking for 2.5 percentage points above its own delivered rate. On that basis LH looks priced roughly in line with its own growth record.
- Implied FCF growth
- 7.9%
- Historical FCF CAGR
- 5.4%
- Growth gap
- +2.5 pts
- Verdict
- FAIR
- Discount rate (WACC)
- 7.55%
- Beta
- 0.63
Behaviour On Record
What LH's own history says about today's numbers
- Realized volatility (21d)
- 18.2% 42nd pct
- Below its peak
- -7.7%
- vs 200-day average
- +11.0%
- Up days (1y)
- 51%
Labcorp Holdings Inc. is currently running 18.2% annualised volatility over the last 21 sessions. Measured against LH's own 13 years of daily returns rather than a market-wide average, that is the 42nd percentile — close to its own typical level, against a typical reading of 19.5%. The distinction matters because a number that looks calm for one stock is turbulent for another, and the absolute figure on its own tells you neither.
LH is trading -7.7% below its running peak. Across 12 full years on file, its median worst-drawdown-in-a-year was -17.3%, and the deepest was -46.6% in 2020. The current pullback is therefore shallower than what this stock gives back in a typical year, which is context worth having before treating it as a dislocation.
Price sits +11.0% from its 200-day moving average. Against every other day in its history, that gap ranks at the 79th percentile — a somewhat wider gap than its own norm. Over the past year LH closed higher on 51% of sessions, and it is currently 2 sessions into a falling streak.
On October specifically: over 14 years of records, LH finished the month higher 10 of 14 times, with a median return of +1.6% and an average of +1.1%. Its strongest month historically has been July at +4.1% on average, its weakest March at -2.8%. Seasonality is a weak signal on its own — a decade is a small sample and regimes change — but it is a real distribution rather than a rule of thumb.
Overnight risk is measurable too: LH has opened more than 2% away from the prior close in 97 of 3,268 sessions (3.0% of the time), with the largest gaps running +27.8% and -7.0%. For anyone holding through an event, that rate is a better guide to overnight exposure than the intraday range.
Across the last 3 dated reports on file, LH moved an average of 1.9% in the session after earnings, closing higher 1 of those 3 times, with a median move of -2.0% and a largest of -2.9%.
All figures computed from 3,269 daily closes between 2013-10-15 and 2026-10-14, split-adjusted, recomputed daily. Percentiles are against LH's own 13-year history, not a peer group or index.
Sector Rotation
Is money rotating into or out of LH's sector?
Labcorp Holdings Inc. sits in the Health Care sector, currently ranked 2nd of 12 GICS sectors by relative-strength rotation score (leading).
- Sector rank
- #2 of 12
- Sector state
- Leading
- Sector rotation score
- 91
Analyst Rating Changes
Are analysts turning bullish or bearish on LH?
Truist Securities most recently reiterated its rating on Labcorp Holdings Inc. to Buy on Sep 21, 2026 with a price target of $365 (from $350). Over the last 90 days, coverage has run 0 upgrades against 0 downgrades, a net mixed lean.
- Latest action
- Truist Securities — Buy
- 90-day upgrades
- 0
- 90-day downgrades
- 0
- Net rating momentum
- 0
Peers & ETF holders
LH peers & ETF holders
Diagnostics & ResearchMarket cap · today
News Sentiment Analysis
Sentiment gathered from recent headlines
Recent News Coverage
Most recent articles, ranked by recency (click to expand).
Technical Analysis
Real-time indicators across multiple timeframes
| Manager | Trend | Shares Held | % of Co. | Position Value | Filed |
|---|---|---|---|---|---|
| Vanguard Group Inc | ▲ Buy | 9,850,631 | 12.15% | $2.47B | 2026-01-29 |
| BlackRock, Inc. | ▲ Buy | 6,574,261 | 8.11% | $1.84B | 2026-08-07 |
| Geode Capital Management, LLC | ▲ Buy | 2,188,890 | 2.70% | $610.44M | 2026-08-12 |
| FMR LLC (Fidelity) | ▲ Buy | 1,904,870 | 2.35% | $533.36M | 2026-08-13 |
| Morgan Stanley | ▲ Buy | 1,609,447 | 1.98% | $450.65M | 2026-08-13 |
| JPMorgan Chase & Co | ▼ Sell | 1,268,384 | 1.56% | $354.62M | 2026-08-12 |
| Invesco Ltd. | ▼ Sell | 1,237,676 | 1.53% | $346.55M | 2026-08-14 |
| Northern Trust Corp | ▼ Sell | 883,076 | 1.09% | $247.26M | 2026-08-13 |
| Wellington Management Group LLP | ▼ Sell | 855,596 | 1.05% | $239.57M | 2026-08-14 |
| Bank of America Corp | ▲ Buy | 812,270 | 1.00% | $227.44M | 2026-08-14 |
| Norges Bank | ▼ Sell | 810,093 | 1.00% | $226.83M | 2026-08-12 |
| Goldman Sachs Group Inc | ▲ Buy | 435,456 | 0.54% | $121.93M | 2026-08-14 |
| AllianceBernstein L.P. | ▼ Sell | 418,385 | 0.52% | $111.63M | 2026-08-14 |
| Wells Fargo & Company | ▲ Buy | 347,544 | 0.43% | $97.31M | 2026-08-14 |
| Squarepoint Ops LLC | ▲ Buy | 258,438 | 0.32% | $72.36M | 2026-08-14 |
| Millennium Management LLC | ▲ Buy | 228,043 | 0.28% | $63.85M | 2026-08-14 |
| Point72 Asset Management, L.P. | ▼ Sell | 137,444 | 0.17% | $38.48M | 2026-08-14 |
| Janus Henderson Group plc | ▼ Sell | 128,871 | 0.16% | $34.38M | 2026-05-18 |
| Citigroup Inc | ▼ Sell | 101,884 | 0.13% | $28.53M | 2026-08-03 |
| Marshall Wace, LLP | ▲ Buy | 96,666 | 0.12% | $27.07M | 2026-08-13 |
| Gotham Asset Management, LLC | ▼ Sell | 90,722 | 0.11% | $25.40M | 2026-08-14 |
| Man Group plc | ▼ Sell | 73,649 | 0.09% | $20.62M | 2026-08-14 |
| AQR Capital Management LLC | ▲ Buy | 60,999 | 0.08% | $16.93M | 2026-08-14 |
| Prudential Financial Inc | ▼ Sell | 44,181 | 0.05% | $12.37M | 2026-08-12 |
| D. E. Shaw & Co., Inc. | ▲ Buy | 40,031 | 0.05% | $11.21M | 2026-08-14 |
| Member | Chamber | State | Type | Amount | Traded | Filed |
|---|---|---|---|---|---|---|
| April McClain Delaney | House | MD06 | ▼ Sell | $100K - $250K | 2026-08-25 | 2026-09-09 |
| April McClain Delaney | House | MD06 | ▼ Sell | $1K - $15K | 2026-08-07 | 2026-09-09 |
| April McClain Delaney | House | MD06 | ▼ Sell | $1K - $15K | 2026-08-06 | 2026-09-09 |
| April McClain Delaney | House | MD06 | ▼ Sell | $1K - $15K | 2026-08-05 | 2026-09-09 |
| Alan Armstrong | Senate | OK | ▲ Buy | $1K - $15K | 2026-03-27 | 2026-07-21 |
| April McClain Delaney | House | MD06 | ▲ Buy | $1K - $15K | 2026-02-11 | 2026-03-10 |
| April McClain Delaney | House | MD06 | ▲ Buy | $1K - $15K | 2026-02-04 | 2026-03-10 |
| April McClain Delaney | House | MD06 | ▲ Buy | $1K - $15K | 2026-01-28 | 2026-02-02 |
| April McClain Delaney | House | MD06 | ▲ Buy | $1K - $15K | 2025-11-17 | 2025-12-08 |
| April McClain Delaney | House | MD06 | ▲ Buy | $1K - $15K | 2025-10-31 | 2025-11-04 |
| April McClain Delaney | House | MD06 | ▲ Buy | $1K - $15K | 2025-10-29 | 2025-11-04 |
| Rob Bresnahan | House | PA08 | ▲ Buy | $1K - $15K | 2025-05-15 | 2025-05-31 |
| Rob Bresnahan | House | PA08 | ▼ Sell | $1K - $15K | 2025-04-08 | 2025-05-08 |
| Gilbert Cisneros | House | CA31 | ▼ Sell | $1K - $15K | 2025-03-31 | 2025-04-07 |
| April McClain Delaney | House | MD06 | ▲ Buy | $1K - $15K | 2025-02-28 | 2025-03-20 |
| April McClain Delaney | House | MD06 | ▲ Buy | $1K - $15K | 2025-02-27 | 2025-03-20 |
| Rob Bresnahan | House | PA08 | ▲ Buy | $1K - $15K | 2025-02-25 | 2025-03-27 |
| April McClain Delaney | House | MD06 | ▲ Buy | $1K - $15K | 2025-02-08 | 2025-03-20 |
| April McClain Delaney | House | MD06 | ▲ Buy | $1K - $15K | 2025-02-05 | 2025-03-20 |
| Dan Sullivan | Senate | AK | ▼ Sell | $1K - $15K | 2023-08-22 | 2023-09-22 |